Literature DB >> 1998646

Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia.

J S Hill1, M R Hayden, J Frohlich, P H Pritchard.   

Abstract

This study explores the influence of selected genetic and environmental factors on the clinical expression of heterozygous familial hypercholesterolemia (FH). A detailed examination of the physical and biochemical features of FH was performed in a large cohort of 208 females and 156 males. Females with FH had higher levels of total, low density lipoprotein (LDL), and high density lipoprotein (HDL) cholesterol when compared with males, although the concentration of HDL cholesterol was significantly lower for both sexes when compared with normals. The reported incidence of coronary artery disease (CAD) was 31% for men and 13% for women, which was lower when compared with figures from previous studies. The average age of onset of coronary symptoms was delayed in females, with a mean age of 55 years compared with 48 years for males (p less than 0.05). A greater risk of developing CAD in men was associated with lower levels of HDL cholesterol and a history of smoking. In women, however, CAD was associated with elevated triglycerides and the presence of hypertension. The frequencies of the epsilon 2, epsilon 3, and epsilon 4 alleles of apolipoprotein E in 125 unrelated FH subjects did not differ significantly from the normal population. In addition, there was no apparent relation between apo E4 and the concentration of any of the parameters in the plasma lipid profile; however, the presence of the E2 isoform was associated with significantly elevated triglycerides in both sexes. This study has allowed us to identify those factors, which, in addition to total cholesterol levels, are associated with the development of premature coronary atherosclerosis in heterozygous FH.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1998646     DOI: 10.1161/01.atv.11.2.290

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  24 in total

Review 1.  Science, medicine, and the future: Genetics and cardiovascular risk.

Authors:  I N Day; D I Wilson
Journal:  BMJ       Date:  2001-12-15

Review 2.  Role of lipid-lowering pharmacotherapy in children.

Authors:  S Tonstad
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

Review 3.  Monogenic hypercholesterolemia: new insights in pathogenesis and treatment.

Authors:  Daniel J Rader; Jonathan Cohen; Helen H Hobbs
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

4.  Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study.

Authors:  E J Sijbrands; R G Westendorp; J C Defesche; P H de Meier; A H Smelt; J J Kastelein
Journal:  BMJ       Date:  2001-04-28

5.  Apolipoprotein E, statins, and risk of intracerebral hemorrhage.

Authors:  Daniel Woo; Ranjan Deka; Guido J Falcone; Matthew L Flaherty; Mary Haverbusch; Sharyl R Martini; Steven M Greenberg; Alison M Ayres; Laura Sauerbeck; Brett M Kissela; Dawn O Kleindorfer; Charles J Moomaw; Christopher D Anderson; Joseph P Broderick; Jonathan Rosand; Carl D Langefeld; Jessica G Woo
Journal:  Stroke       Date:  2013-09-05       Impact factor: 7.914

6.  Reply: Pseudoexfoliation syndrome and cardiovascular disease: studies must control for all cardiovascular risk factors.

Authors:  K A Gonen; T Gonen; B Gumus
Journal:  Eye (Lond)       Date:  2013-08-23       Impact factor: 3.775

Review 7.  Familial hypercholesterolemia: developments in diagnosis and treatment.

Authors:  Gerald Klose; Ulrich Laufs; Winfried März; Eberhard Windler
Journal:  Dtsch Arztebl Int       Date:  2014-08-04       Impact factor: 5.594

8.  A novel approach to screening for familial hypercholesterolemia in a large public venue.

Authors:  Megan Campbell; Jessa Humanki; Heather Zierhut
Journal:  J Community Genet       Date:  2016-11-26

9.  European workshop on LDL receptor defects. European Working Group on Familial Hypercholesterolaemia.

Authors:  H Schuster; S Humphries
Journal:  Clin Investig       Date:  1994-11

10.  Mutations in the low-density-lipoprotein receptor gene in German patients with familial hypercholesterolaemia.

Authors:  N Weiss; G Binder; C Keller
Journal:  J Inherit Metab Dis       Date:  2000-12       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.